glioblastoma

Showing NaN - NaN of 56

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma Trial in United States (Ad-RTS-hIL-12, veledimex)

Completed
  • Glioblastoma
  • Los Angeles, California
  • +3 more
Sep 21, 2021

Glioblastoma Trial in United States (NeuroBlate System, Radiation therapy and temozolomide)

Terminated
  • Glioblastoma
  • NeuroBlate System
  • Radiation therapy and temozolomide
  • Saint Louis, Missouri
  • +3 more
Aug 23, 2021

Brain Cancer, Brain Tumor, Glioma Trial in Canada, United States (DNX-2401, pembrolizumab)

Completed
  • Brain Cancer
  • +10 more
  • DNX-2401
  • pembrolizumab
  • Little Rock, Arkansas
  • +14 more
Jul 13, 2021

Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Houston (Mefloquine, Memantine Hydrochloride, Metformin

Active, not recruiting
  • Glioblastoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 16, 2021

Glioblastoma Trial in United States (Pembrolizumab, Bevacizumab)

Completed
  • Glioblastoma
  • Los Angeles, California
  • +7 more
Nov 30, 2020

Glioblastoma Trial in Worldwide (BKM120 + temozolomide, BKM120 +temozolomide with/without radiotherapy)

Completed
  • Glioblastoma
  • BKM120 + temozolomide
  • BKM120 +temozolomide with/without radiotherapy
  • Fayetteville, Arkansas
  • +7 more
Dec 6, 2020

Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

Terminated
  • Malignant Melanoma
  • +7 more
  • Gilbert, Arizona
  • +29 more
Sep 21, 2020

Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma Trial in Houston (Educational Intervention, Questionnaire

Recruiting
  • Glioblastoma
  • +2 more
  • Educational Intervention
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 20, 2020

Glioblastoma, Anaplastic Astrocytoma Trial in Houston (ADV/HSV-tk (gene therapy))

Recruiting
  • Glioblastoma
  • Anaplastic Astrocytoma
  • ADV/HSV-tk (gene therapy)
  • Houston, Texas
    Houston Methodist Neurological Institute
Sep 3, 2020

B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),

Completed
  • B-cell Malignancies
  • +7 more
  • Nivolumab (Phase 1)
  • +4 more
  • Birmingham, Alabama
  • +23 more
Aug 26, 2020

Brain Cancer, Glioblastoma Trial in Houston (Standard Dose Bevacizumab, Low Dose Bevacizumab, Lomustine)

Completed
  • Brain Cancer
  • Glioblastoma
  • Standard Dose Bevacizumab
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 10, 2020

Glioblastoma Trial in Houston (Computed Tomography, Fluciclovine F18, Positron Emission Tomography)

Unknown status
  • Glioblastoma
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 25, 2019

Glioblastoma Trial in Worldwide (enzastaurin, lomustine)

Completed
  • Glioblastoma
  • Phoenix, Arizona
  • +97 more
Sep 10, 2019

Anaplastic Astrocytoma, Brain Stem Glioma, Childhood Mixed Glioma Trial in United States (radiation, other, drug)

Completed
  • Anaplastic Astrocytoma
  • +12 more
  • 3-Dimensional Conformal Radiation Therapy
  • +5 more
  • Los Angeles, California
  • +11 more
Jul 17, 2019

Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Canada, Israel, United States (radiation, biological, other,

Completed
  • Glioblastoma
  • +2 more
  • 3-Dimensional Conformal Radiation Therapy
  • +6 more
  • Mobile, Alabama
  • +329 more
Jul 22, 2019

Glioblastoma Trial in United States (BKM120, Surgery)

Completed
  • Glioblastoma
  • Los Angeles, California
  • +6 more
Mar 5, 2019

Glioblastoma, Gliosarcoma Trial in Houston (Temozolomide, Radiation, Sorafenib)

Terminated
  • Glioblastoma
  • Gliosarcoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 7, 2018

Glioblastoma, CNS Disease, Brain Diseases Trial in Houston (Dasatinib, RT (Radiotherapy), TMZ (Temozolomide))

Terminated
  • Glioblastoma
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Nov 7, 2018

Glioblastoma Trial in Canada, Israel, United States (VB-111 + bevacizumab, Bevacizumab)

Completed
  • Glioblastoma
  • Birmingham, Alabama
  • +56 more
Oct 22, 2018

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (FDOPA PET)

Terminated
  • Glioma
  • +2 more
  • FDOPA PET
  • Houston, Texas
    Houston Methodist Research Institute PET Center
Aug 15, 2018

Anaplastic Astrocytoma, Anaplastic Ependymoma, Astrocytoma, Grade II Trial in United States (imetelstat sodium)

Terminated
  • Anaplastic Astrocytoma
  • +8 more
  • imetelstat sodium
  • Los Angeles, California
  • +10 more
Jun 20, 2018

Glioblastoma Trial in Houston (Macitentan in combination with RT and TMZ)

Terminated
  • Glioblastoma
  • Macitentan in combination with RT and TMZ
  • Houston, Texas
    MD Anderson Cancer Center
Feb 26, 2018

Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in Worldwide (Rindopepimut (CDX-110) with GM-CSF,

Completed
  • Glioblastoma
  • +4 more
  • Rindopepimut (CDX-110) with GM-CSF
  • +2 more
  • Birmingham, Alabama
  • +222 more
Jan 11, 2018

Teratoid Tumor, Atypical, Choroid Plexus Tumors, Anaplastic Astrocytoma Trial in United States (azurin-derived cell-penetrating

Completed
  • Teratoid Tumor, Atypical
  • +9 more
  • azurin-derived cell-penetrating peptide p28
  • Los Angeles, California
  • +10 more
Aug 3, 2017